The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
sodium 2-(2-(2-(4-benzhydrylpiperazin-1-yl)-2-oxoethoxy)acetamido)-5-chlorobenzoate ID: ALA5200284
Cas Number: 1103926-82-4
PubChem CID: 53240409
Product Number: T287019, Order Now?
Max Phase: Preclinical
Molecular Formula: C28H27ClN3NaO5
Molecular Weight: 522.00
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COCC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)Nc1ccc(Cl)cc1C(=O)[O-].[Na+]
Standard InChI: InChI=1S/C28H28ClN3O5.Na/c29-22-11-12-24(23(17-22)28(35)36)30-25(33)18-37-19-26(34)31-13-15-32(16-14-31)27(20-7-3-1-4-8-20)21-9-5-2-6-10-21;/h1-12,17,27H,13-16,18-19H2,(H,30,33)(H,35,36);/q;+1/p-1
Standard InChI Key: JSHSGBIWNPQCQZ-UHFFFAOYSA-M
Molfile:
RDKit 2D
38 40 0 0 0 0 0 0 0 0999 V2000
-4.9998 -1.4415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2852 -1.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5733 -1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5733 -2.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2834 -2.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9998 -2.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8587 -1.0285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1441 -1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 -1.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1441 -2.2663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 -1.4411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -1.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4290 -1.0285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -2.2663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2852 -0.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9998 0.2085 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5706 0.2085 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4290 -0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1436 0.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8583 -0.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8583 -1.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1436 -1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5729 0.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5729 1.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2875 -0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8584 1.4471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8591 2.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5739 2.6826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2859 2.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2906 1.4487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0023 0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7144 -0.2029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7144 -1.0284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0042 -1.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2875 -1.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7144 -2.6826 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.7025 0.6374 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
2 16 1 0
16 17 2 0
16 18 1 0
19 14 1 0
20 19 1 0
21 20 1 0
22 21 1 0
23 22 1 0
14 23 1 0
21 24 1 0
24 25 1 0
24 26 1 0
27 25 2 0
28 27 1 0
29 28 2 0
30 29 1 0
31 30 2 0
25 31 1 0
32 26 2 0
33 32 1 0
34 33 2 0
35 34 1 0
36 35 2 0
26 36 1 0
6 37 1 0
M CHG 2 18 -1 38 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 522.00Molecular Weight (Monoisotopic): 521.1717AlogP: 3.93#Rotatable Bonds: 9Polar Surface Area: 99.18Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.37CX Basic pKa: 7.17CX LogP: 1.72CX LogD: 1.39Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: -1.38
References 1. Li X, Guo T, Feng Q, Bai T, Wu L, Liu Y, Zheng X, Jia J, Pei J, Wu S, Song Y, Zhang Y.. (2022) Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs., 228 [PMID:34902735 ] [10.1016/j.ejmech.2021.114035 ]